Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 96-week results of a randomised, double-blind, non-inferiority, phase 3 trial
Molina, Jean-Michel, Squires, Kathleen, Sax, Paul E, Cahn, Pedro, Lombaard, Johan, DeJesus, Edwin, Lai, Ming-Tain, Rodgers, Anthony, Lupinacci, Lisa, Kumar, Sushma, Sklar, Peter, Hanna, George J, HwanJournal:
The Lancet HIV
DOI:
10.1016/S2352-3018(19)30336-4
Date:
November, 2019
File:
PDF, 570 KB
2019